IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company’s development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.
Metrics to compare | IRME | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIRMEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.0x | −3.3x | −0.7x | |
PEG Ratio | −0.04 | 0.03 | 0.00 | |
Price/Book | −3.6x | 4.1x | 2.6x | |
Price / LTM Sales | - | 5.6x | 3.4x | |
Upside (Analyst Target) | - | 186.8% | 37.8% | |
Fair Value Upside | Unlock | 7.7% | 5.3% | Unlock |